Weiss-Aug, a provider of advanced manufacturing and engineering solutions, revealed a rebranding initiative to streamline organizational structure and unify market presence.

The company will move from operating as a group and multiple divisions, which were previously named after acquired businesses. It will operate as two new business units: Weiss-Aug and Weiss-Aug MedPharma, serving two distinct industry segments.

Weiss-Aug will serve the industrial and commercial markets, specializing in high-volume metal stamping, thermoplastic molding, and value-added assembly solutions for the aerospace & defense, automotive, interconnect, telecommunications and consumer goods industries.

Weiss-Aug MedPharma will serve the medical and pharma industries, mainly focused on medical devices, orthopedic solutions, and drug delivery technologies. Specializing in precision machining, laser processing, and insert molding, it will be dedicated to the development and manufacturing of high-quality, precision medical components, assemblies, and finished devices.

RELATED: Weiss-Aug Group Debuts Precision Tech Manufacturing Division

Lupine Research will remain its R&D center for artificial intelligence, machine learning and materials science, supporting both units.

The reorganization follows development of two new facilities in N.J. and Pa. with more than 144,000 square feet of manufacturing space.

“Our new structure represents a significant step forward in aligning our brand with the value we bring to our customers,” said Elisabeth Weissenrieder-Bennis, president of the company. “By retiring legacy names from past acquisitions and uniting our capabilities under these focused business units, we are better positioned to deliver industry-specific expertise, drive innovation, and scale with our customers’ needs.”